Parkinson's Postdoctoral Fellows at Van Andel Research Institute in U.S.A.

Van Andel Research Institute’s P. Brundin Laboratory, under the direction of Patrik Brundin, M.D., Ph.D., has positions available for multiple Postdoctoral Fellows.

The Patrik Brundin lab focus on pathogenetic mechanisms and pharmacological treatment in cell and animal models of Parkinson's disease. They also study cell replacement therapy with stem cells in attempts to repair brains in animal models of parkinsonism. The group's mission is to understand neurodegenerative diseases and develop new therapies that are of benefit to patients and their caregivers.

Recently, the lab been involved in one of the most promising developments for a cure, or at least progress in fighting Parkinson’s disease. A new investigational drug originally developed for type 2 diabetes is being readied for human clinical trials in search of the world's first treatment to impede the progression of Parkinson's disease following publication of the lab’s new research.

These postdoctoral positions are available IMMEDIATELY and are for motivated scientists who meet the qualifications and description outlined below. These fellows will investigate the contribution of genes and the environment to Parkinson’s disease pathogenesis.

Further details:
http://euraxess.duth.gr